ATI22-107 is a dual-pharmacophore inhibitor targeting phosphodiesterase type III (PDE-III) and L-type calcium channels (LTCC). This compound enhances calcium cycling and contractility in cardiac tissues, particularly in cat ventricular myocytes and trabeculae. It is valuable for research focused on cardiac function, calcium signaling, and the pharmacological modulation of heart contractility.
ATI22-107 is a dual-pharmacophore inhibitor targeting phosphodiesterase type III (PDE-III) and L-type calcium channels (LTCC). This compound enhances calcium cycling and contractility in cardiac tissues, particularly in cat ventricular myocytes and trabeculae. It is valuable for research focused on cardiac function, calcium signaling, and the pharmacological modulation of heart contractility.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
